MEMORIAL SLOAN KETTERING CANCER CENTER VP of Investor Relations Salary | Comparably
MSK is the world's oldest and largest private institution devoted to the prevention, treatment, and cure of cancer. Founded in 1884, MSK has long been a leader in early detection, precise diagnosis, and individually tailored treatments for cancer. We continue to drive innovations as one of 52 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment. The close collaboration between our scientists and physicians is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future scientists and physicians, and the knowledge and experience they gain at MSK has an impact on cancer treatment and biomedical research around the world. read more
EMPLOYEE
PARTICIPANTS
96
TOTAL
RATINGS
943
HR or Marketing? Claim Your Free Employer Account

MEMORIAL SLOAN KETTERING CANCER CENTER VP of Investor Relations Salary

$77k
$120k
$129k
$225k
N/A
Average Compensation

VP of Investor Relations Salaries at MEMORIAL SLOAN KETTERING CANCER CENTER

* estimated salary

Compensation at MEMORIAL SLOAN KETTERING CANCER CENTER by Department

The Communications Department averages $46,151 more than the Enterprise Risk Department.

Communications
$218,431 Avg. total comp.
Enterprise Risk
$172,280 Avg. total comp.
-$46k
Product
$135,526 Avg. total comp.
-$83k

How VPs of Investor Relations at MEMORIAL SLOAN KETTERING CANCER CENTER Rate Their Compensation

The majority of VPs of Investor Relations at MEMORIAL SLOAN KETTERING CANCER CENTER believe they're compensated fairly. 80% of VPs of Investor Relations at MEMORIAL SLOAN KETTERING CANCER CENTER say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at MEMORIAL SLOAN KETTERING CANCER CENTER

×
Rate your company